Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06235697 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Study acronym: ASCENDE-SBRT
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 53 → 57 locationsv12
  2. Re-verified, no change to tracked fieldsv11
  3. Study sites: 23 to 53v10
  4. Study sites: 13 to 23v9
  5. Eligibility criteria expanded, about 12 wordsv8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 12 to 13v7
  2. Study sites: 9 to 12v6
  3. Study sites: 8 to 9v5
  4. Study sites: 1 to 8
    • Interventions: Radiation (Radiation), Radiation SBRT only (Radiation) to ADT (Drug), Radiation (Radiation), Radiation SBRT only (Radiation)
    v4
  5. Study site revisedv3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 31, 2024 to Apr 25, 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being done to answer the following question: Is the strategy to give higher doses of radiotherapy treatment over a shorter period of time using special equipment and fewer treatments (also known as Stereotactic Body Radiation Therapy or SBRT) as effective as usual external radiation therapy given with a brachytherapy boost (which involves radiation sources inserted directly into the prostate)?
Trial Details
NCT Number NCT06235697
Lead Sponsor Canadian Cancer Trials Group
Collaborators: NRG Oncology
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 710 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov